CPIX
Cumberland Pharmaceuticals Inc
NASDAQ: CPIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.19
-0.48% today
Updated 2026-04-30
Market cap
$60.72M
P/E ratio
—
P/S ratio
1.36x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $6
Volume
1.2M
Cumberland Pharmaceuticals Inc (CPIX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-6.37%
Operating margin
-10.00%
ROE
-12.20%
ROA
-2.29%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $17.82M | $4.40M | 86.53% | 12.48% | 24.72% |
| 2007 | $28.06M | $4.04M | 90.49% | 23.96% | 14.41% |
| 2008 | $35.08M | $4.77M | 91.32% | 20.76% | 13.59% |
| 2009 | $43.54M | $3.09M | 90.50% | 13.27% | 7.10% |
| 2010 | $45.88M | $2.46M | 92.18% | 14.17% | 5.36% |
| 2011 | $51.14M | $5.66M | 89.51% | 19.26% | 11.06% |
| 2012 | $48.85M | $5.84M | 89.67% | 18.05% | 11.96% |
| 2013 | $32.03M | $-2.10M | 83.02% | -11.87% | -6.57% |
| 2014 | $36.90M | $2.42M | 86.31% | 9.64% | 6.57% |
| 2015 | $33.52M | $731351.00 | 85.18% | -3.32% | 2.18% |
| 2016 | $33.03M | $-944683.00 | 81.96% | -4.34% | -2.86% |
| 2017 | $41.15M | $-7.98M | 82.09% | -9.92% | -19.39% |
| 2018 | $40.74M | $-6.96M | 81.89% | -18.14% | -17.09% |
| 2019 | $34.39M | $-3.54M | 78.42% | -27.01% | -10.29% |
| 2020 | $37.44M | $-3.34M | 76.89% | -17.04% | -8.92% |
| 2021 | $35.99M | $-3.51M | 75.51% | -21.34% | -9.75% |
| 2022 | $42.01M | $-5.57M | 78.29% | -13.58% | -13.26% |
| 2023 | $39.55M | $-6.28M | 84.66% | -24.16% | -15.88% |
| 2024 | $37.87M | $-6.48M | 82.61% | -16.99% | -17.11% |
| 2025 | $44.52M | $-2.84M | 85.02% | -6.27% | -6.37% |